Neuroproprioceptive Equine-Assisted Physiotherapy for Spinal Muscular Atrophy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-9
SponsorCharles University, Czech Republic

About this trial

This study investigates whether Equine-Assisted Physiotherapy based on Neuro-proprioceptive "Facilitation and Inhibition" (NEUROEQUIP-SMA) can improve movement, posture, breathing, and quality of life in children with spinal muscular atrophy (SMA). This therapy uses the horse's rhythmic movement together with targeted sensory and manual stimulation to trigger natural motor reactions starting from the pelvis, lower the threshold for muscle activation, and support coordinated motor patterns. The study compares this method with standard individual physiotherapy based on the same neuro-proprioceptive facilitation and inhibition principles, but performed without the horse. Twenty children aged 2 to 9 years will receive both therapies in two separate 6-day blocks, in random order (crossover design). The researchers will assess muscle fatigue, coordination, breathing function, movement quality and quantity, quality of life, and changes in selected blood biomarkers. The results may help develop better rehabilitation strategies for children with SMA who are receiving modern pharmacological or gene therapy.

Eligibility criteria

Qualifiers

Age between 2 and 9 years

Clinical diagnosis of spinal muscular atrophy (SMA) type I, II, or III

Stable health condition for at least 6 months prior to enrollment

Ability to participate in the study procedures

Disqualifiers

Hip dislocation

Known allergy to horses or the stable environment

Severe fear of horses that would prevent participation in equine-assisted physiotherapy

Trial design

Treatments tested in this trial

  • Equine-Assisted Physiotherapy based on Neuro-proprioceptive "Facilitation and Inhibition"
  • Standard Individual Outpatient Physiotherapy Based on Neuro-proprioceptive Facilitation and Inhibition
  • Therapeutic grooming

Treatment groups

20 Participants
are divided into 2 treatment groups